The Complete Consumer Guide to Naproxen Sodium: Uses, Dosage, Warnings, and Latest Innovations
No systemic anti-inflammatory is without biological trade-offs. The primary mechanism granting naproxen its pain-relieving power also underlies its main liabilities. By suppressing COX-1 enzymes, naproxen inadvertently limits the production of protective gastric prostaglandins that maintain the mucosal lining of the stomach and regulate regional blood flow.
This suppression can cause gastrointestinal side effects ranging from mild acid reflux, nausea, and abdominal cramping to erosive gastritis, peptic ulcers, and gastrointestinal perforation. Older adults (aged 65 and up), individuals with a history of stomach ulcers, and those concurrently taking anticoagulants, oral corticosteroids, or SSRIs face elevated hemorrhage risks. Persistent dark stools or sharp epigastric pain warrants immediate medical evaluation.
From a vascular standpoint, regulatory agencies require black-box warnings on all non-aspirin NSAIDs regarding cardiovascular risk factors. These agents can promote fluid retention, elevate systemic blood pressure, and increase the hazard of myocardial infarction or stroke. While observational registries indicate naproxen carries a somewhat lower thrombotic risk profile than high-dose diclofenac or celecoxib, individuals with uncontrolled hypertension, congestive heart failure, or established coronary artery disease should avoid routine use unless cleared by a cardiologist.